Form 8-K · Current report
News Corp 8-K, filed Aug 11, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000177
Summary
News Corp repurchased 62,323 shares of its Class A common stock for about US$1.77 million on 10 August 2026 under its 2025 repurchase program, which authorizes up to US$1 billion in aggregate of Class A and Class B common stock. Cumulative purchases under the program total roughly US$415.3 million, and the buy-back transactions are disclosed daily to the Australian Securities Exchange.
Key points
- On 10 August 2026 News Corp bought back 62,323 Class A common shares for US$1,773,787.37, at prices between US$28.20 and US$28.62.
- Total shares bought back or subject to acceptances to date under the program: 10,534,376, for total consideration of US$269,013,236.05.
- The company has purchased approximately US$415,315,621 worth of Class A and Class B shares (based on total consideration paid) under the 2025 Repurchase Program.
- Goldman Sachs & Co. LLC is named as broker for the buy-back; repurchases may occur in the open market or otherwise, and no ASX-listed CDIs will be repurchased.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.